Glucophage

GPTKB entity

Statements (53)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:bfsLayer 4
gptkbp:bfsParent gptkb:Metformin
gptkbp:activities increases insulin sensitivity
decreases hepatic glucose production
enhances peripheral glucose uptake
gptkbp:approves gptkb:1994
gptkb:FDA
gptkbp:brand gptkb:Metformin
gptkb:Xigduo_XR
gptkb:Riomet
gptkb:Janumet
gptkb:Fortamet
gptkb:Metformin_ER
Glumetza
Kombiglyze XR
Synjardy
gptkbp:clinical_trial studies on efficacy
studies on safety
studies on long-term effects
studies on combination therapy
studies on weight loss effects
gptkbp:contraindication renal impairment
acute or chronic metabolic acidosis
gptkbp:dosage_form 500 mg
1000 mg
extended-release tablet
850 mg
gptkbp:formulation gptkb:tablet
gptkb:item
https://www.w3.org/2000/01/rdf-schema#label Glucophage
gptkbp:ingredients gptkb:metformin
gptkbp:interacts_with gptkb:beer
corticosteroids
beta-blockers
certain diuretics
gptkbp:is_available_on generic medication
gptkbp:is_used_for type 2 diabetes
gptkbp:manager oral
gptkbp:manufacturer gptkb:Bristol-Myers_Squibb
gptkbp:scholarships stay hydrated
monitor blood sugar levels
exercise regularly
maintain a balanced diet
consult doctor before stopping medication
gptkbp:side_effect nausea
stomach upset
diarrhea
lactic acidosis
gptkbp:storage room temperature
away from moisture
away from heat
gptkbp:traded_on gptkb:Glucophage_XR